Copyright
©The Author(s) 2022.
World J Orthop. Jun 18, 2022; 13(6): 587-602
Published online Jun 18, 2022. doi: 10.5312/wjo.v13.i6.587
Published online Jun 18, 2022. doi: 10.5312/wjo.v13.i6.587
Table 1 The main characteristics of the platelet-rich plasma protocols used in the study
Arthrex ACP | Mini GPS III | Xerthra | Dr. PRP | |
Amount of blood collected | 13.5 mL | 27 mL | 13.5 mL | 18 mL |
Final amount of PRP | 4 mL | 3 mL | 1.5 mL | 3 mL |
Drawn blood/obtained PRP | 3.38:1 | 9:1 | 9:1 | 6:1 |
Anticoagulant type | ACD-A | ACD-A | 3.13% SOD CITR | 3.13% SOD CITR |
Anticoagulant amount | 1.5 mL | 3 mL | 1.5 mL | 2 mL |
Number of spins | 1 | 1 | 1 | 1 |
RPM | 1500 | 3200 | 3500 | 3100 |
Centrifugation time | 5’ | 15’ | 5’ | 4’ |
Removal of PPP | no | yes | yes | yes |
Expected WBC content | low | high, 5x | low | low |
Expected PLT concentration | 2-3 x | 9.3 x | 2-13 x | 4-5 x |
Dedicated centrifuge | Yes | Yes | Yes | Yes |
Activation method | In vivo | In vivo | In vivo | In vivo |
Type of PRP | Conditioned Plasma | LR-PRP | LP-PRP | LP-PRP |
Table 2 Whole blood count with differential leukocyte of all participants
Differential leukocyte | Blood count |
RBC (1012/L) | 4.97 ± 0.43 |
PLT (109/L) | 240.67 ± 49.85 |
WBC (109/L) | 6.49 ± 1.49 |
Neutrophils (109/L) | 3.79 ± 1.29 |
Lymphocytes (109/L) | 2.08 ± 0.45 |
Monocytes (109/L) | 0.45 ± 0.13 |
Eosinophils (109/L) | 0.14 ± 0.08 |
Basophils (109/L) | 0.04 ± 0.01 |
Table 3 Concentrations of blood cell components in platelet-rich plasma samples
Arthrex ACP | Mini GPS III | Xerthra | Dr. PRP | |
PLT (109/L) | 357.33 ± 99.01 | 1212.67 ± 268.63 | 455.27 ± 362.92 | 499.75 ± 153.46 |
WBC (109/L) | 0.87 ± 1.01 | 34.19 ± 11.18 | 1.80 ± 2.55 | 0.60 ± 0.87 |
Neutrophils (109/L) | 0.87 ± 1.01 | 16.71 ± 9.89 | 1.80 ± 2.55 | 0.60 ± 0.87 |
RBC (1012/L) | 0.05 ± 0.08 | 1.49 ± 0.86 | 0.02 ± 0.02 | 0.01 ± 0.01 |
xPLT | 1.47 ± 0.18 | 5.05 ± 0.67 | 1.96 ± 1.71 | 2.14 ± 0.73 |
xWBC | 0.14 ± 0.17 | 5.27 ± 1.41 | 0.29 ± 0.4 | 0.10 ± 0.16 |
xRBC | 0.01 ± 0.02 | 0.30 ± 0.17 | 0.00 | 0.00 |
Table 4 The coefficient of variation in the concentration of blood cell components for different platelet-rich plasma preparation systems
WBC | RBC | PLT | |
Arthrex ACP [%] | 114.80 | 175.69 | 12.18 |
Mini GPS III [%] | 26.79 | 56.83 | 13.25 |
Xerthra [%] | 149.38 | 133.98 | 95.95 |
Dr. PRP [%] | 151.45 | 95.10 | 34.05 |
- Citation: Dejnek M, Witkowski J, Moreira H, Płaczkowska S, Morasiewicz P, Reichert P, Królikowska A. Content of blood cell components, inflammatory cytokines and growth factors in autologous platelet-rich plasma obtained by various methods. World J Orthop 2022; 13(6): 587-602
- URL: https://www.wjgnet.com/2218-5836/full/v13/i6/587.htm
- DOI: https://dx.doi.org/10.5312/wjo.v13.i6.587